Review

Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of the hydroperoxide-reducing proteins from human blood plasma

Correspondence to: Yorihiro Yamamoto.

Plasma glutathione peroxidase (GSHPx) has been suggested to reduce submicromolar levels of free fatty acid hydroperoxides and phosphatidylcholine hydroperoxides (PC-OOH), and therefore these hydroperoxides are undetectable in human blood plasma. The capacity for the reduction should be about 2.5 µM as the level of glutathione in human plasma is about 5 µM. However, 2 h of aerobic incubation of 58 µM PC-OOH in human plasma at 37°C resulted in the formation of 36 µM phosphatidylcholine hydroxide (PC-OH). The presence of PC-OOH-reducing protein other than plasma GSHPx was suggested by the results. a) The same rates of PC-OOH decay and PC-OH formation were observed in both sera from rats with selenium-deficient and selenium-supplemented diet; b) the PC-OOH-reducing activity was observed only in the high molecular weight fraction but not in the low molecular weight fraction; and c) albumin did not work as a reducing substrate of plasma GSHPx. We have isolated two hydroperoxide-reducing protein fractions from human plasma by a sequential purification scheme, comprising an ammonium sulfate precipitation followed by sequential chromatography on anion exchange, hydrophobic interaction, and heparin columns. One of the proteins was identified as apolipoprotein A-I by N-terminal amino acid sequence analysis. Moreover, the hydroperoxide-reducing activity of one of the fractions was inhibited almost completely by the addition of anti-apolipoprotein A-I antibody.

These findings demonstrate that apolipoprotein A-I in high density lipoprotein can reduce PC-OOH to PC-OH.—Mashima, R., Y. Yamamoto, and S. Yoshimura. Reduction of phosphatidylcholine hydroperoxide by apolipoprotein A-I: purification of th hydroperoxide-reducing proteins from human blood plasma. J. Lipid Res. 1998. 39: 1133–1140.

Supplementary key words: phosphatidylcholine hydroxide, selenium-deficient, selenium-supplemented, plasma glutathione peroxidase, high density lipoprotein, peroxidase

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. W. C. Brock, A. J. Jenkins, T. J. Lyons, R. L. Klein, E. Yim, M. Lopes-Virella, R. E. Carter, (DCCT/EDIC) Research Group, S. R. Thorpe, and J. W. Baynes Increased methionine sulfoxide content of apoA-I in type 1 diabetes J. Lipid Res., April 1, 2008; 49(4): 847 - 855. [Abstract] [Full Text] [PDF]

				R. Stocker and J. F. Keaney Jr. Role of Oxidative Modifications in Atherosclerosis Physiol Rev, October 1, 2004; 84(4): 1381 - 1478. [Abstract] [Full Text] [PDF]

				G. Pankhurst, X. L. Wang, D. E. Wilcken, G. Baernthaler, U. Panzenbock, M. Raftery, and R. Stocker Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein J. Lipid Res., February 1, 2003; 44(2): 349 - 355. [Abstract] [Full Text] [PDF]

				E. Boisfer, D. Stengel, D. Pastier, P. M. Laplaud, N. Dousset, E. Ninio, and A.-D. Kalopissis Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II J. Lipid Res., May 1, 2002; 43(5): 732 - 741. [Abstract] [Full Text] [PDF]

				R. Mashima, L. Tilley, M.-A. Siomos, V. Papalexis, M. J. Raftery, and R. Stocker Plasmodium falciparum Histidine-rich Protein-2 (PfHRP2) Modulates the Redox Activity of Ferri-protoporphyrin IX (FePPIX). PEROXIDASE-LIKE ACTIVITY OF THE PfHRP2-FePPIX COMPLEX J. Biol. Chem., April 19, 2002; 277(17): 14514 - 14520. [Abstract] [Full Text] [PDF]

				H. Cao, A. Girard-Globa, F. Berthezene, and P. Moulin Paraoxonase protection of LDL against peroxidation is independent of its esterase activity towards paraoxon and is unaffected by the Q->R genetic polymorphism J. Lipid Res., January 1, 1999; 40(1): 133 - 139. [Abstract] [Full Text]

				U. Panzenbock, L. Kritharides, M. Raftery, K.-A. Rye, and R. Stocker Oxidation of Methionine Residues to Methionine Sulfoxides Does Not Decrease Potential Antiatherogenic Properties of Apolipoprotein A-I J. Biol. Chem., June 23, 2000; 275(26): 19536 - 19544. [Abstract] [Full Text] [PDF]

				Z. Ahmed, A. Ravandi, G. F. Maguire, A. Emili, D. Draganov, B. N. L. Du, A. Kuksis, and P. W. Connelly Apolipoprotein A-I Promotes the Formation of Phosphatidylcholine Core Aldehydes That Are Hydrolyzed by Paraoxonase (PON-1) during High Density Lipoprotein Oxidation with a Peroxynitrite Donor J. Biol. Chem., June 29, 2001; 276(27): 24473 - 24481. [Abstract] [Full Text] [PDF]